Pulse & Remedy claims peptide therapy "is considered safe for extended use" without citing a study behind that statement, underscoring the regulatory gap between non-prescription peptides and FDA-approved GLP-1 drugs
The FDA has approved several GLP-1 agonist medicines for different uses
For the full efficacy picture on each medication, see our semaglutide statistics report and tirzepatide statistics report for 2026
This is particularly important for distinguishing retatrutide from truncated or scrambled sequences that might co-elute on HPLC
He provides physician-led care focused on medication tolerability, long-term metabolic outcomes, and safe, sustainable weight loss through both in-person and telehealth visits across Southern and Northern Utah
These reductions appeared partially independent of weight loss, suggesting potential direct anti-inflammatory effects